Literature DB >> 3977958

Enhancement of reactive oxygen-dependent mitochondrial membrane lipid peroxidation by the anticancer drug adriamycin.

E G Mimnaugh, M A Trush, M Bhatnagar, T E Gram.   

Abstract

Mitochondrial degeneration is a consistently prominent morphological alteration associated with adriamycin toxicity which may be the consequence of adriamycin-enhanced peroxidative damage to unsaturated mitochondrial membrane lipids. Using isolated rat liver mitochondria as an in vitro model system to study the effects of the anticancer drug adriamycin on lipid peroxidation, we found that NADH-dependent mitochondrial peroxidation--measured by the 2-thiobarbituric acid method--was stimulated by adriamycin as much as 4-fold. Marker enzyme analysis indicated that the mitochondria were substantially free of contaminating microsomes (less than 5%). Lipid peroxidation in mitochondria incubated in KCl-Tris-HCl buffer (pH 7.4) under an oxygen atmosphere was optimal at 1-2 mg of mitochondrial protein/ml and with NADH at 2.5 mM. Malonaldehyde production was linear with time to beyond 60 min, and the maximum enhancement of peroxidation was observed with adriamycin at 50-100 microM. Interestingly, in contrast to its stimulatory effect on NADH-supported mitochondrial peroxidation, adriamycin markedly diminished ascorbate-promoted lipid peroxidation in mitochondria. Superoxide dismutase, catalase, 1,3-dimethylurea, reduced glutathione, alpha-tocopherol and EDTA added to incubation mixtures inhibited endogenous and adriamycin-augmented NADH-dependent peroxidation of mitochondrial lipids, indicating that multiple species of reactive oxygen (superoxide anion radical, hydrogen peroxide and hydroxyl radical) and possibly trace amounts of endogenous ferric iron participated in the peroxidation reactions. In submitochondrial particles freed of endogenous defenses against oxyradicals, lipid peroxidation was increased 7-fold by adriamycin. These observations suggest that some of the effects of adriamycin on mitochondrial morphology and biochemical function may be mediated by adriamycin-enhanced reactive oxygen-dependent mitochondrial lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3977958     DOI: 10.1016/0006-2952(85)90766-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  19 in total

1.  The Antioxidant Effects of Thymoquinone in Activated BV-2 Murine Microglial Cells.

Authors:  Makini K Cobourne-Duval; Equar Taka; Patricia Mendonca; David Bauer; Karam F A Soliman
Journal:  Neurochem Res       Date:  2016-09-01       Impact factor: 3.996

2.  Adriamycin induced myocardial failure in rats: protective role of Centella asiatica.

Authors:  A Gnanapragasam; S Yogeeta; R Subhashini; K K Ebenezar; V Sathish; T Devaki
Journal:  Mol Cell Biochem       Date:  2006-06-20       Impact factor: 3.396

3.  The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice.

Authors:  H C Yen; T D Oberley; S Vichitbandha; Y S Ho; D K St Clair
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

4.  The iron(III) and copper(II) complexes of adriamycin promote the hydrolysis of the cardioprotective agent ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane).

Authors:  B B Hasinoff
Journal:  Agents Actions       Date:  1990-03

Review 5.  Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

6.  The influence of lipoic acid on adriamycin induced nephrotoxicity in rats.

Authors:  Kumaravel Palanichamy Malarkodi; Andithangal Venkatesan Balachandar; Palaninathan Varalakshmi
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

Review 7.  Oxidative stress in chemical toxicity.

Authors:  H Kappus
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

8.  Inhibition and inactivation of NADH-cytochrome c reductase activity of bovine heart submitochondrial particles by the iron(III)-adriamycin complex.

Authors:  B B Hasinoff
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

9.  The iron(III)-adriamycin complex inhibits cytochrome c oxidase before its inactivation.

Authors:  B B Hasinoff; J P Davey
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

10.  Effect of antioxidants on adriamycin-induced microsomal lipid peroxidation.

Authors:  H Hida; C Coudray; J Calop; A Favier
Journal:  Biol Trace Elem Res       Date:  1995 Jan-Mar       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.